Apeloa's Ante Yutai, WuXi Biologics, Duoning Sign Five-Year Strategic Framework without Specific Projects

Apeloa Pharmaceutical's controlled subsidiary, Zhejiang Ante Yutai Biotechnology Co. , Ltd. , has signed a strategic cooperation framework agreement with Shanghai WuXi Biologics Co. and Shanghai Duoning Biotechnology Co. The three parties plan to establish a long-term strategic partnership to advance the development of biopharmaceutical pipelines, build industrialization capacity, and improve the supply chain system. The agreement is valid for five years and does not involve specific projects or amounts. It will not have a material impact on the company's operating results for the current fiscal year.